What is Timely by DrFirst?
Headquartered in Rockville, Maryland, DrFirst has been a pioneer in healthcare technology since 2000. The company specializes in creating unconventional solutions that shatter information silos, effectively connecting providers, patients, and payers at every touchpoint of care. Their core competencies include advanced medication management, care collaboration, and price transparency tools designed to improve patient outcomes and operational efficiency.
By integrating these services into existing clinical workflows, Timely by DrFirst addresses the complex challenges of medication adherence and data interoperability. The company occupies a unique niche in the health-tech market, serving as a critical infrastructure provider that enables seamless communication and data exchange, thereby reducing administrative burdens and enhancing the quality of care delivered in diverse clinical settings.
How much funding has Timely by DrFirst raised?
Timely by DrFirst has raised a total of $142.5M across 7 funding rounds:
Debt
$10M
Multiple Rounds
$65.5M
Unspecified
$17M
Other Financing Round
$50M
Debt (2014): $10M with participation from Silicon Valley Bank
Private Equity (2015): $3.5M, investors not publicly disclosed
Debt (2015): $12M supported by SunTrust Bank
Private Equity (2015): $25M featuring Goldman Sachs
Private Equity (2015): $25M backed by Goldman Sachs
Unspecified (2019): $17M with participation from SunTrust Banks
Other Financing Round (2021): $50M led by Sixth Street
Key Investors in Timely by DrFirst
Goldman Sachs
Goldman Sachs is a leading global investment banking, securities, and investment management firm providing a wide range of financial services to corporations and institutional clients.
Sixth Street
Sixth Street is a global investment firm with significant assets under management, known for its strategic stakes in high-growth companies across various sectors.
SunTrust Banks
SunTrust Banks is a diversified financial service holding company providing a range of credit, trust, and investment services to corporate and consumer clients.
What's next for Timely by DrFirst?
With the recent capital injection, Timely by DrFirst is poised to scale its enterprise-level operations and deepen its investment in R&D. The strategic focus will likely center on expanding its suite of digital health tools to address emerging challenges in medication management and patient engagement. By further refining its proprietary technology, the company aims to solidify its market leadership and continue driving innovation in care collaboration.
The infusion of funds provides the necessary runway to explore new market segments and enhance existing service offerings, ensuring that the company remains at the forefront of the healthcare technology revolution. As the industry moves toward more integrated and data-driven care models, the firm is strategically aligned to capitalize on these shifts, fostering sustainable growth and delivering enhanced value to its institutional partners and the broader healthcare community.
